
JIANGSU WANHAI MEDICAL INSTRUMENTS CO, LTD
About us
Wanhai Medical, founded in 2016 in Changzhou, Jiangsu, has specialized in the R&D, production and sales of various pen injectors for 10 years.
With over 300 employees, the company operates a 12,000-square-meter factory, and its annual production capacity exceeds 120 million pen injectors. Wanhai Medical serves over 80 countries and regions worldwide, working with more than 260 well-known pharmaceutical companies. After the completion of a new 38,000-square-meter factory, the total annual production capacity will reach 400 million units.
Wanhai Medical holds certifications including CE, ISO 13485, NMPA, and CDE, and is currently pursuing FDA and MDSAP certifications.
Wanhai Medical is dedicated to developing and manufacturing high-quality reusable pen injectors, disposable (prefilled) pen injectors, and auto-injectors. These products are ideal for the treatment of insulin, GLP-1, and other hormone-based and monoclonal antibody drugs. These include growth hormone (HGH), GLP-1 (semaglutide, liraglutide, teriparatide, etc.), follicle-stimulating hormone (FSH), parathyroid hormone (PTH), and adrenaline.